Zaile Zhuang

Zaile Zhuang

Auto-generated profile, based on publicly available information

Zaile Zhuang

Department of Chemical and Systems Biology, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2022 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ZZZaile Zhuang
Zaile Zhuang
SCSteven W. Cummings
Steven W. Cummings
ARAntonina Roll-Mecak
Antonina Roll-Mecak
MTMartin E. Tanner
Martin E. Tanner
Phosphinic acid-based inhibitors of tubulin polyglycylation are identified.

14 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZZZaile Zhuang
Zaile Zhuang
RTRiley K. Togashi
Riley K. Togashi
PKPatrick Kearney
Patrick Kearney
IPIan Pass
Ian Pass
SSSteven M. Swick
Steven M. Swick
JCJames K. Chen
James K. Chen
Homeodomain-interacting protein kinase 4 (HIPK4) is a dual-specificity kinase that is predominantly expressed in differentiating spermatids, required for sperm development, and a promising target for nonhormonal male contraception. Genetic and functional studies have established an essential role for HIPK4 in spermiogenesis, where it acts at least in part through regulation of the F-actin-scaffolded acroplaxome during spermatid head shaping. The direct molecular targets of HIPK4 and their downstream effectors remain poorly defined, and small-molecule probes would be versatile tools for further investigating HIPK4 functions. Synthetic HIPK4 ligands could also be valuable leads for the development of nonhormonal male contraceptives. Here, we report the discovery of a cyanoquinoline-based series of HIPK4 inhibitors with nanomolar potency. Our lead compounds are selective for HIPK4, both within the HIPK family and across the broader kinome, establishing this scaffold as a useful starting point for probe and lead development. Unexpectedly, we found that a subset of these cyanoquinolines also perturbs HIPK4 proteostasis in a cell type-specific manner. In spermatids, these compounds induce the formation of detergent-insoluble HIPK4 aggregates and promote interactions between this kinase and the autophagy receptor Tax1-binding protein 1 (TAX1BP1). Together, our findings establish cyanoquinoline ligands as a new chemotype for probing HIPK4 biology and advancing male contraceptive discovery.

24 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAthina Zerva
Athina Zerva
NRNicolai D. Raig
Nicolai D. Raig
ZZZaile Zhuang
Zaile Zhuang
AKAndreas Kraemer
Andreas Kraemer
JDJohannes Dopfer
Johannes Dopfer
THThomas Hanke
Thomas Hanke
Homeodomain-interacting protein kinase 4 (HIPK4) remains an understudied member of the dark kinome. While genetic knockout studies suggest roles for HIPK4 in spermiogenesis and cutaneous squamous cell carcinoma, whether these cellular functions can be recapitulated by pharmacological inhibition remains to be determined. However, such investigations have been hampered by a lack of high-quality chemical tools. To address this, we employed a rational design strategy utilizing macrocyclization of a bosutinib-based scaffold. Systematic optimization led to the discovery of AZ137 ( 28e ), a potent and selective HIPK4 inhibitor (IC 50 = 11 nM; cellular EC 50 = 76 nM). AZ137 exhibits exceptional selectivity across three comprehensive orthogonal panels, high solubility, and no detectable cytotoxicity. Its cellular activity was confirmed in cell-based assays of HIPK4-dependent F-actin remodeling. Together with a negative control compound, this probe set provides a foundational framework for the validating HIPK4 as a therapeutic target and a high-quality resource to elucidate its roles in normal physiology and disease.